Seres Therapeutics (MCRB) Receivables - Other (2016 - 2025)
Seres Therapeutics (MCRB) has disclosed Receivables - Other for 8 consecutive years, with $53000.0 as the latest value for Q3 2025.
- Quarterly Receivables - Other changed N/A to $53000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $53000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $2.7 million for FY2024, 69.07% down from the prior year.
- Receivables - Other hit $53000.0 in Q3 2025 for Seres Therapeutics, down from $279000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $125.0 million in Q1 2023 to a low of $53000.0 in Q3 2025.
- Historically, Receivables - Other has averaged $22.4 million across 3 years, with a median of $2.7 million in 2024.
- Biggest five-year swings in Receivables - Other: crashed 69.07% in 2024 and later plummeted 98.5% in 2025.
- Year by year, Receivables - Other stood at $8.7 million in 2023, then plummeted by 69.07% to $2.7 million in 2024, then crashed by 98.02% to $53000.0 in 2025.
- Business Quant data shows Receivables - Other for MCRB at $53000.0 in Q3 2025, $279000.0 in Q2 2025, and $1.6 million in Q1 2025.